Hi Ian,
Having introduced HDF therapy with the 5008 at one of our units in Dorset earlier this year, we have been through the same problems with validation of the infusion fluid. The RA guidelines are quite clear about the limits as you say, less than 1 in 1000L and 0.03EU/ml. The problem this gives is that the only way to be 100% sure that the fluid meets this standard is to filter 1000L and see no growth, the direct inoculation method using 1ml would not give a high enough confidence level.
This is obviously impractical, so after talking to the microbiologist at our lab we agreed that they would filter a 1L sample (1L being the most we could practically draw off regularly and that they could process) taken from the 5008 safeline directly into a sterile prime bag. This was done with random machines regularly over a three month period to cover ultrafilter changes, we also sent control samples of fluid that would not meet this standard.
All infusion fluid samples came back showing no growth in 1L and less than 0.03 EU/ml (I would have liked do quantative endotoxin down to 0.01 but our lab could not do it at the time).
This validation period coupled with the 5008 ultrafilter integrity test has given us the confidence to stop regular testing of the infusion fluid, we now only take 100ml samples of water from septum ports at the machine inlet to check they meet ultrapure standard. Chemical analysis is still done three monthly.
As there are no further guidelines from the RA, this is what we felt comfortable with. Hopefully the next revision of the guidelines will be more explicit.
BR
Fraser